Viewing Study NCT04344158

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:58 PM

Ignite Modification Date: 2025-12-25 @ 9:55 PM

Study NCT ID: NCT04344158

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-02-20

First Post: 2020-04-10

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module